🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Based on recent evidence on the mutation of the A/H3N2 strain in egg-grown ...
Status
Unknown
Location
Insight Therapeutics, LLC
Start Date
2019-07-20
Trial ID
NCT03965195
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Peninsula Research Associates Site Number : 8400013
Start Date
2022-04-11
Trial ID
NCT06118151
Treatments Being Tested
This is a multi-center, randomized, double-blind, active comparator control...
Status
Unknown
Location
Optimal Research
Start Date
2015-05
Trial ID
NCT02434276
Treatments Being Tested
This is a prospective, randomized clinical trial. During the study, pregnan...
Status
Completed
Location
Boston Medical Center
Start Date
2019-09-05
Trial ID
NCT03969641
Treatments Being Tested
This Phase 2, randomized, observer-blind, active controlled clinical study ...
Status
Completed
Location
4022 - Coastal Clinical Research, an AMR company
Start Date
2020-10-08
Trial ID
NCT04576702
Treatments Being Tested
* To describe the immune response induced by quadrivalent recombinant influ...
Status
Completed
Location
Investigational Site Number :4100003
Start Date
2021-12-07
Trial ID
NCT05144945
Flublok was studied previously in children 6 -59 months of age and demonstr...
Status
Completed
Location
Maine Research Associates, LLC
Start Date
2013-11
Trial ID
NCT01959945
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of a...
Status
Completed
Location
Peninsula Research Associates Site Number : 8400025
Start Date
2022-10-03
Trial ID
NCT05553301
The purpose of this study was to evaluate the safety and immunogenicity of ...
Status
Completed
Location
California Research Foundation Site Number : 8400038
Start Date
2024-04-01
Trial ID
NCT06361875
The objective of this study is to evaluate the safety and immunogenicity of...
Status
Completed
Location
Paratus Clinical
Start Date
2025-03-19
Trial ID
NCT06850051
Treatments Being Tested